Nishadil
Signup Signin
Delhi | 25°C (windy)
A New Beacon of Hope: Bristol Myers Squibb's Breyanzi Achieves Fifth FDA Approval

A New Beacon of Hope: Bristol Myers Squibb's Breyanzi Achieves Fifth FDA Approval
Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership
Merus Buyout Frenzy: Genmab Rumored to Lead the Race, Sending Retail Traders Into a Tizzy

Merus Buyout Frenzy: Genmab Rumored to Lead the Race, Sending Retail Traders Into a Tizzy
Biotech Blockbuster Alert: Genmab Edges Closer to Game-Changing Merus Acquisition

Biotech Blockbuster Alert: Genmab Edges Closer to Game-Changing Merus Acquisition
Load more..